Literature DB >> 16171723

Autologous bone marrow mononuclear cells labeled with Tc-99m hexamethylpropylene amine oxime scintigraphy after intracoronary stem cell therapy in acute myocardial infarction.

Claudio T Mesquita1, Patrícia L Correa, Renata C Felix, Jader C Azevedo, Susana Alves, Cristina C Oliveira, André Luiz S Sousa, Radovan Borojevic, Hans Fernando R Dohmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16171723     DOI： 10.1016/j.nuclcard.2005.05.010

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  7 in total

1.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors:  Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

2.  The new-generation positron emission tomography/computed tomography scanners: implications for cardiac imaging.

Authors:  Stephen L Bacharach
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

3.  Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Claudio T Mesquita; Maria I D Rossi; Antonio C Carvalho; Helio S Dutra; Hans J F Dohmann; Guilherme V Silva; Luciano Belém; Ricardo Vivacqua; Fernando O D Rangel; Roberto Esporcatte; Yong J Geng; William K Vaughn; Joao A R Assad; Evandro T Mesquita; James T Willerson
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

4.  Bone marrow cells regenerate infarcted myocardium.

Authors:  D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

Review 5.  Clinical applications of stem cells for the heart.

Authors:  Kai C Wollert; Helmut Drexler
Journal:  Circ Res       Date:  2005-02-04       Impact factor: 17.367

6.  Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.

Authors:  M B Britten; N D Abolmaali; B Assmus; R Lehmann; J Honold; J Schmitt; T J Vogl; H Martin; V Schächinger; S Dimmeler; A M Zeiher
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

7.  Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study.

Authors:  Shmuel Fuchs; Lowell F Satler; Ran Kornowski; Petros Okubagzi; Giora Weisz; Richard Baffour; Ron Waksman; Neil J Weissman; Manuel Cerqueira; Martin B Leon; Stephen E Epstein
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094
  7 in total
  8 in total

Review 1.  SPECT and PET to optimize cardiac stem cell therapy.

Authors:  Angel T Chan; M Roselle Abraham
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

Review 2.  Stem Cell Monitoring with a Direct or Indirect Labeling Method.

Authors:  Min Hwan Kim; Yong Jin Lee; Joo Hyun Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-10-22

3.  Stem cell tracking in human trials: a meta-regression.

Authors:  Peter McColgan; Pankaj Sharma; Paul Bentley
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

Review 4.  Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging.

Authors:  Peter J Gawne; Francis Man; Philip J Blower; Rafael T M de Rosales
Journal:  Chem Rev       Date:  2022-05-12       Impact factor: 72.087

5.  Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.

Authors:  Virginie F Forest; Ashok M Tirouvanziam; Christian Perigaud; Sarah Fernandes; Marion S Fusellier; Jean-Claude Desfontis; Claire S Toquet; Marie-Françoise M Heymann; Dominique P Crochet; Patricia F Lemarchand
Journal:  Stem Cell Res Ther       Date:  2010-03-15       Impact factor: 6.832

6.  Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.

Authors:  Shih-Hsun Cheng; Dou Yu; Hsiu-Ming Tsai; Ramin A Morshed; Deepak Kanojia; Leu-Wei Lo; Lara Leoni; Yureve Govind; Lingjiao Zhang; Karen S Aboody; Maciej S Lesniak; Chin-Tu Chen; Irina V Balyasnikova
Journal:  J Nucl Med       Date:  2015-11-12       Impact factor: 10.057

7.  Hepatic targeting and biodistribution of human fetal liver stem/progenitor cells and adult hepatocytes in mice.

Authors:  Kang Cheng; Daniel Benten; Kuldeep Bhargava; Mari Inada; Brigid Joseph; Christopher Palestro; Sanjeev Gupta
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.298

8.  Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity.

Authors:  Eugene Gu; Wen-Yi Chen; Jay Gu; Paul Burridge; Joseph C Wu
Journal:  Theranostics       Date:  2012-04-01       Impact factor: 11.556
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.